Holen Sie sich die Stockscreener-App
5.43
1.31%
0.07
Schlusskurs vom Vortag:
$5.36
Offen:
$5.47
24-Stunden-Volumen:
558.41K
Relative Volume:
0.69
Marktkapitalisierung:
$278.19M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-54.19M
KGV:
-2.1047
EPS:
-2.58
Netto-Cashflow:
$-37.34M
1W Leistung:
+1.69%
1M Leistung:
-15.55%
6M Leistung:
+18.04%
1J Leistung:
-15.29%
1-Tages-Spanne:
$5.211
$5.4751
1-Wochen-Bereich:
$5.211
$5.73
52-Wochen-Spanne:
$3.9328
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Firmenname
Abeona Therapeutics Inc
Sektor
Branche
Telefon
646-813-4701
Adresse
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Vergleichen Sie ABEO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
5.425 | 274.85M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.07 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.04 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
551.61 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
809.47 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.09 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-03-05 | Eingeleitet | Oppenheimer | Outperform |
| 2024-07-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-05-30 | Eingeleitet | Stifel | Buy |
| 2020-11-11 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | Eingeleitet | B. Riley FBR | Buy |
| 2020-02-10 | Eingeleitet | SVB Leerink | Outperform |
| 2019-12-10 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2019-08-15 | Herabstufung | Maxim Group | Buy → Hold |
| 2019-08-12 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-06-27 | Eingeleitet | Mizuho | Buy |
| 2018-10-12 | Eingeleitet | Mizuho | Buy |
| 2018-06-05 | Eingeleitet | Seaport Global Securities | Buy |
| 2017-11-08 | Eingeleitet | SunTrust | Buy |
| 2017-10-16 | Bestätigt | H.C. Wainwright | Buy |
| 2017-10-11 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-10-10 | Eingeleitet | Citigroup | Buy |
| 2017-10-05 | Bestätigt | Maxim Group | Buy |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-07-18 | Bestätigt | Maxim Group | Buy |
| 2017-06-22 | Fortgesetzt | Jefferies | Buy |
| 2017-01-06 | Eingeleitet | Jefferies | Buy |
| 2016-09-29 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Abeona Therapeutics Inc Aktie (ABEO) Neueste Nachrichten
Abeona Therapeutics Inc. stock daily chart insightsJuly 2025 Momentum & AI Powered Buy and Sell Recommendations - newser.com
Is Abeona Therapeutics Inc. stock oversold or undervaluedWeekly Risk Report & Reliable Intraday Trade Alerts - newser.com
Abeona Therapeutics Inc. stock trend forecastJuly 2025 Setups & Expert-Curated Trade Recommendations - newser.com
Abeona Therapeutics (ABEO) Joins FDA's RDEA Pilot Program for Ge - GuruFocus
Abeona’s gene therapy for rare eye disease selected for FDA pilot program - Investing.com Nigeria
H.C. Wainwright reaffirms Buy rating on Abeona Therapeutics stock at $20 - Investing.com UK
ABEO Stock: HC Wainwright Reiterates Buy Rating Maintaining $20 Price Target | ABEO Stock News - GuruFocus
Abeona Therapeutics® Announces ABO-503 Gene Therapy for - GlobeNewswire
Why Abeona Therapeutics Inc. is moving todayDollar Strength & Real-Time Buy Signal Alerts - newser.com
3 Top Growth Stocks Insiders Are Eager To Hold - Yahoo Finance
Abeona Therapeutics (NASDAQ:ABEO) Stock Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Is Abeona Therapeutics Inc. (PCJ) stock a top dividend aristocrat candidate2025 Market Trends & Fast Entry High Yield Stock Tips - newser.com
Will Abeona Therapeutics Inc. (PCJ) stock benefit from Fed rate cutsMarket Sentiment Summary & Verified Technical Trade Signals - newser.com
Is Abeona Therapeutics Inc a good long term investmentWeekly Market Snapshot & Small Entry Portfolio - earlytimes.in
Is Abeona Therapeutics Inc. (PCJ) stock a good hedge against inflationTake Profit & Growth Oriented Trade Recommendations - newser.com
What drives Abeona Therapeutics Inc stock priceMoving Average Crossovers & Free High Margin Investment Plays - earlytimes.in
Abeona Therapeutics' (ABEO) "Hold (C-)" Rating Reiterated at Weiss Ratings - MarketBeat
Abeona Therapeutics (ABEO) Expands Treatment Options for RDEB Pa - GuruFocus
Abeona Therapeutics and Children's Hospital Colorado Activate New Center for ZEVASKYN Treatment of Recessive Dystrophic Epidermolysis Bullosa - Quiver Quantitative
Abeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene Therapy - The Manila Times
Abeona Therapeutics® and Children's Hospital Colorado - GlobeNewswire
Children's Hospital Colorado named newest QTC for Abeona's FDA‑approved ZEVASKYN to treat RDEB - Stock Titan
What analysts say about Abeona Therapeutics Inc PCJ stockPrice Volatility Patterns & Outstanding Return Stocks - earlytimes.in
What drives Abeona Therapeutics Inc PCJ stock priceDividend Cut Warnings & Low Cost Capital Trading - earlytimes.in
Will Abeona's Gene Therapy For Dystrophic Epidermolysis Bullosa Achieve Wider Adoption? - RTTNews
Abeona Therapeutics Inc Stock Analysis and ForecastBull Market Opportunities & Small Budget Capital Investment - earlytimes.in
Analyzing drawdowns of Abeona Therapeutics Inc. with statistical tools2025 Volume Leaders & Technical Analysis for Trade Confirmation - newser.com
Market reaction to Abeona Therapeutics Inc.’s recent newsQuarterly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
What’s next for Abeona Therapeutics Inc. stock priceJuly 2025 Fed Impact & Daily Stock Trend Reports - newser.com
Analyzing recovery setups for Abeona Therapeutics Inc. investorsQuarterly Market Summary & Free Risk Controlled Daily Trade Plans - newser.com
Understanding Abeona Therapeutics Inc.’s price movementIPO Watch & Short-Term Swing Trade Alerts - newser.com
Why Abeona Therapeutics Inc. (PCJ) stock attracts HNW investorsJuly 2025 Retail & Technical Pattern Alert System - newser.com
Can Abeona Therapeutics Inc. stock sustain free cash flow growthMarket Risk Analysis & Short-Term Trading Alerts - newser.com
Order flow analysis tools used on Abeona Therapeutics Inc.July 2025 Trade Ideas & Community Verified Trade Alerts - newser.com
Will Abeona Therapeutics Inc. stock maintain momentum in 2025Trade Analysis Summary & Weekly Market Pulse Updates - newser.com
Finanzdaten der Abeona Therapeutics Inc-Aktie (ABEO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Abeona Therapeutics Inc-Aktie (ABEO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Seshadri Vishwas | Chief Executive Officer |
Sep 30 '25 |
Sale |
5.24 |
25,000 |
130,930 |
1,190,067 |
| Seshadri Vishwas | Chief Executive Officer |
Sep 29 '25 |
Sale |
5.39 |
19,274 |
103,954 |
1,215,067 |
| Vazzano Joseph Walter | Chief Financial Officer |
Sep 29 '25 |
Sale |
5.39 |
9,035 |
48,730 |
453,631 |
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):